Remember peeking through a View-Master? Scientists are using the same concept behind the classic kids' toy to try to see mammograms in 3-D
Cheryl Reed's morning routine starts like that of millions of other mothers around the country. She makes breakfast for her 8-year-old son and 6-year-old daughter, piles them into a minivan and drops them off at school.
Get your daughters off the couch: New research shows exercise during the teen years -- starting as young as age 12 -- can help protect girls from breast cancer when they're grown
A recent green light from regulators could mean a brighter outlook from Genentech when the biotech meets with analysts Friday.
Let's face it: There's no body part women obsess about more than breasts -- their size, shape, sag factor, and whether those strange pains stem from monthly PMS hormones or something more ominous, like breast cancer.
Nikki Caldwell's got 10 weeks to sell Pat Summitt on the sidecar.
With no work on Wisteria Lane these days (thanks to the Hollywood writers' strike), Desperate Housewives's Marcia Cross put her free time to use this week, lobbying Congress to pass 12-year-old legislation for breast cancer patients.
Genentech, the word's largest biotech in terms of market capitalization, reported a healthy increase in sales and earnings for the fourth quarter.
A new study shows that this once-popular breast-cancer therapy proves ineffective
So you're scared of breast cancer. Smart lady. Nearly 200,000 women will learn they have breast cancer this year, and you don't want to be one of them. You're doing everything you can to make sure you're not next -- doing breast exams, getting mammograms -- but you think it would be great if you could get a test to see if you'll develop breast cancer.
Remember peeking through a View-Master? Scientists are using the same concept behind the classic kids' toy to try to see mammograms in 3-D
Cheryl Reed's morning routine starts like that of millions of other mothers around the country. She makes breakfast for her 8-year-old son and 6-year-old daughter, piles them into a minivan and drops them off at school.
Get your daughters off the couch: New research shows exercise during the teen years -- starting as young as age 12 -- can help protect girls from breast cancer when they're grown
A recent green light from regulators could mean a brighter outlook from Genentech when the biotech meets with analysts Friday.
Let's face it: There's no body part women obsess about more than breasts -- their size, shape, sag factor, and whether those strange pains stem from monthly PMS hormones or something more ominous, like breast cancer.
Nikki Caldwell's got 10 weeks to sell Pat Summitt on the sidecar.
With no work on Wisteria Lane these days (thanks to the Hollywood writers' strike), Desperate Housewives's Marcia Cross put her free time to use this week, lobbying Congress to pass 12-year-old legislation for breast cancer patients.
Genentech, the word's largest biotech in terms of market capitalization, reported a healthy increase in sales and earnings for the fourth quarter.
A new study shows that this once-popular breast-cancer therapy proves ineffective
So you're scared of breast cancer. Smart lady. Nearly 200,000 women will learn they have breast cancer this year, and you don't want to be one of them. You're doing everything you can to make sure you're not next -- doing breast exams, getting mammograms -- but you think it would be great if you could get a test to see if you'll develop breast cancer.
Genentech scientists won't waste any time fretting the FDA panel decision to reject Avastin as a breast cancer treatment. The reason: The biotech giant has at least three clinical breast cancer trials underway - at least one of which is likely to succeed.
A panel of FDA advisors did not support the use of Genentech's Avastin as a breast cancer drug.
Genentech Inc. faces a high-stakes decision by a government panel Wednesday over the cancer drug Avastin.
Cathy Bueti was widowed at the age of 25 when her husband was killed in a car accident. Seven years later, she says, "I finally started to feel like my life was coming back together, then I found the lump."
In discussions about breast cancer, the male form of the disease is often overlooked -- so, men end up going longer without diagnosis or treatment
New research shows the adage "what doesn't kill us makes us stronger" doesn't apply in treating breast cancer.
Actress Jaclyn Smith will never forget the day she found out she had breast cancer. And she'll never forget the lesson she learned in those very first moments of being a cancer patient.
Genentech reported a surge in third-quarter earnings that barely beat Wall Street projections, while its revenue increase fell just short of estimates.
A small California drug company hopes to extract the next cancer cure from Chinese herbs
Two studies show that chemotherapy doesn't work equally well for all cancers, raising hopes of tailoring the treatment
We've heard for nearly a decade about the benefits of alcohol -- red wine in particular. It's good for your heart and may have other positive effects. In moderation, we thought, it's not only OK, but actually good for us.
Bristol-Myers Squibb faces a moment of truth this month when the FDA decides whether its experimental chemotherapy for breast cancer is good enough for the U.S. market.
Invasive breast cancer rates have fallen since the substantial decline in postmenopausal hormone replacement therapy occurred, even after a decline in breast cancer screening rates, according to findings published in the 5th Journal of the National Cancer Institute.
Eli Lilly & Co.'s osteoporosis drug Evista reduces the risk of breast cancer in some patients, but at a cost of an increased risk of serious side effects, regulatory reviewers said in documents released Friday.
Breast cancer survivors who ate more fruits and vegetables were not more likely to avoid a cancer recurrence
What's scarier than mad cow disease? Nothing, really -- except illnesses that are 10 billion times more likely to hurt you. Think about it this way: Your risk of getting mad cow is much lower than your odds of winning the Powerball lottery. In short, it's not likely to happen. What could happen? In her lifetime, the average woman has a 1 in 2 chance of developing osteoporosis and a 1 in 3 chance of heart disease.
It started with a pain behind the nipple. Within a few weeks, a lump started to grow. It got bigger and more painful until a doctor finally diagnosed stage 4 breast cancer. It's a story shared by thousands around the United States, only in this case, the patient's name is Bill Morley.
A genetic mutation that raises the risk of breast cancer is found in up to 60 percent of U.S. women, making it the first truly common breast cancer susceptibility gene, researchers report.
Stalled sales, failed drug experiments and an SEC inquiry are among the problems nagging at Amgen and Genentech as the world's two biggest biotech companies get set to report first-quarter earnings.
The American Cancer Society is recommending MRIs in addition to mammograms for certain women considered to be at unusually high risk for breast cancer. Here are more details:
In light of Elizabeth Edwards' recurrent breast cancer, CNN Medical News producer Shahreen Abedin spoke with Dr. Rache Simmons, breast surgeon at the New York-Presbyterian Weill-Cornell Medical Center's Breast Cancer Center. Dr. Simmons has never treated Elizabeth Edwards, so the answers she gives are mainly about metastatic breast cancer in general, unless otherwise specified.
Elizabeth and John Edwards on Thursday described her cancer recurrence as a chronic condition that she'll have the rest of her life.
The Food and Drug Administration approved GlaxoSmithKline's breast cancer drug Tykerb, the drug company said Tuesday.
The Food and Drug Administration is expected to approve a breast cancer treatment from GlaxoSmithKline on Tuesday, analysts say.
Nancy Brinker said that her sister might not have foreseen her legacy, but she knew Brinker would tackle breast cancer head on.
Scientists said on Thursday that an experimental drug from GlaxoSmithKline to treat late-stage breast cancer has also shown promise in treating early stages of the disease.
The number of new breast cancer cases dropped by 7 percent in 2003, according to research presented at a breast cancer conference in San Antonio, Texas, on Thursday. But some cancer experts wonder whether the decline will last. CNN's Soledad O'Brien discussed the new findings with Chief Medical Correspondent Dr. Sanjay Gupta.
As Breast Cancer Awareness Month draws to a close, CNN.com asked readers to share their stories. Here is a sampling of responses, some of which have been edited:
This summer retired computer consultant Carleton Neville went online, took out his credit card, and ordered a $500 colon cancer test from DNA Direct, a San Francisco genetic-testing service.
Sandra Mahncke thought she was coming down with the flu in late April, but instead of a quick recovery, she has spent the last five months in a race for her life.
Earlier this year, rock singer Sheryl Crow underwent minimally invasive surgery for breast cancer.
Tykerb, an experimental new drug from GlaxoSmithKline, significantly slowed the spread of breast cancer in clinical trials, according to study results released Saturday.
Despite the Memorial Day holiday, there was no rest for obesity researchers in the major medical journals.
Amgen and Genentech, the long-ruling kings of the cancer drug market, could find the lucrative business growing more crowded as potential new competitors come to market.
More than 30 years have passed since President Richard Nixon declared a "war on cancer," and while no single cure has been found, many new treatments have come to market.
European health authorities have recommended the approval of Herceptin for a broader use in breast cancer treatment, which might help Genentech get the drug approved for a larger patient population in the U.S.
Forget earlier reports on pregnancy concerns, two studies published this week in major medical journals said.
Getting sued seems to be the price of doing business for Big Pharma, and Wyeth has once again joined the ranks of the defendants.
Unexpected benefit
Mixed message
The "lower is better" cholesterol story has been around for decades, but this week researchers reported in the New England Journal of Medicine that a lifetime of low cholesterol looks like a superior way to avoid heart disease.
Domagoj Vucic didn't come to Genentech for the rich stock options or the free cappuccino or the made-to-order sushi or the parties every Friday night. He came from the University of Georgia seven y...
Genentech is still the darling of the biotech industry. The problem is everyone knows it.
An eclectic week
An experimental drug combination from Wyeth helps women in the advanced stages of breast cancer live longer, the company said Thursday.
The Food and Drug Administration approved the combined use of Tarceva, an anti-cancer drug from Genentech and OSI Pharmaceuticals, with chemotherapy to treat pancreatic cancer, the companies said.
Kathy Hudson, 43, received the call in her classroom surrounded by 20 rowdy 4-year olds.
Drug safety made headlines in the major medical journals this week when noted Cleveland Clinic cardiologists came up with a disturbing analysis about a new diabetes drug that is just a hair away from approval by the Food and Drug Administration.
In 1987, around one in four women age 50 and older said they'd had a mammogram and breast exam in the past two years. Eleven years later, that number jumped to 69 percent.
Drug sales for cancer treatments are expected to more than double over the next five years, with cancer drugs replacing cholesterol-reducers as the number one pharmaceutical sector, according to a report from IMS Health.
Even in the mute efficiency of international wire transfers, $540 million makes a noise when it lands in your bank account. To Kent Alexander, that sound was a thud--and in this case "not one singl...
Genentech could get another lift in sales for a drug-chemo combination already projected as a blockbuster, and women at risk for heart disease could have a safer option for treating breast cancer.
Smaller tumors, better outcomes
Better care for women cited
Pop singer Kylie Minogue's manager has confirmed she will undergo surgery this week for breast cancer.
Pop singer Kylie Minogue has begun treatment for breast cancer at a private Catholic hospital in the southern Australian city of Melbourne.
DARLENE NIPPER GOT ALMOST NOTHING BUT awful news in the early weeks of September 2003. First she learned that the two-centimeter lump in her left breast--the one her gynecologist had responded to b...
Herceptin, Genentech's drug for fighting some late-stage breast cancer, could potentially double its sales if approved by the Food and Drug Administration to fight cancer in the early stages.
Big drugmakers look poised to reap the benefits of the FDA's recent guidelines encouraging the biotech industry to develop "targeted" drugs.
When cancer first touched my life in 1984, there were no pink ribbons, no 5K races for "the cure" and few support groups to rely upon. Cancer was the kind of word you whispered and prayed didn't strike your family.
Bob Riter speaks to breast cancer patients, usually women, about something they can relate to -- his own experience with the disease.
Melissa Etheridge's powerful performance at the 2005 Grammy Awards rocked and resonated with the thousands in attendance and millions more watching on television. Her distinctive voice and hard-strummed guitar echoed throughout the hall, as did her energy.
Novartis AG won U.S. approval to market the drug Femara for women who have finished standard therapy for early-stage breast cancer, the company said Friday.
From "Wolf Blitzer Reports" correspondent Jennifer Coggiola:
Increased use of antibiotics may heighten women's risk of breast cancer, a study looking at possible connections between the two suggests.
When Genentech announced the clinical success of its new cancer drug, Avastin, on May 19, investors were having a terrible Monday. Most stocks got clobbered--at the close the Dow had sweated off 18...
"I wondered if it would be inevitable" that I would get breast cancer, says a young brunette in a dramatic TV ad that has been airing in Denver and Atlanta for the past six months; soon the campaig...
In the summer of 2000, ice cream and frozen yogurt maker Dreyer's decided to try to link its name to the hugely popular cause of fighting breast cancer. It had watched other companies conduct campa...
Idec Pharmaceuticals, a San Diego biotech company, is hardly a household name. But that's not stopping investors. Its new drug, Rituxan, is rapidly becoming a key weapon in the war against lymphoma...
Many of the 29 million American women at high risk for breast cancer who want to take the drug tamoxifen will have to wait at least six months for their health plans to approve such treatment.
When future historians finish deflating the late 20th century, an era acutely distended by hype, they'll probably be left with just two events worth entire chapters. One was the advent of the compu...
HELP FOR A BRAVE WOMAN
On the sandy volleyball court behind a Monona, Wis. neighborhood bar, a fragile-looking woman wearing an oversize lavender T-shirt leaps to slam the ball over the net, her short-cropped blonde hair...
| Most Viewed | Most Emailed | Top Searches |
| Most Viewed | Most Emailed | Top Searches |
Video
Photos
